Doxycycline Suppresses Hypertension through Renin– Angiotensin System (RAS) Regulation: Insights from Molecular Docking and Renal Gene Expression

Ariski Fajarido; Fadilah Fadilah; Wawaimuli Arozal; Jaka Fajar Fatriansyah; Agrin Febrian Pradana; Edwina Rugayah Monayo

doi:10.21705/mcbs.v10i1.744

Doxycycline Suppresses Hypertension through Renin– Angiotensin System (RAS) Regulation: Insights from Molecular Docking and Renal Gene Expression

Ariski Fajarido, Fadilah Fadilah, Wawaimuli Arozal, Jaka Fajar Fatriansyah, Agrin Febrian Pradana, Edwina Rugayah Monayo

Abstract

Background: Doxycycline, a tetracycline antibiotic known for inhibiting matrix metalloproteinases, has shown potential antihypertensive effects. However, its role in modulating the renin–angiotensin system remains poorly understood. This study aims to specifically evaluate Doxycycline’s effects on key RAS components and blood pressure responses to clarify its underlying mechanism and support its development as a targeted antihypertensive therapeutic candidate.

Materials and Methods: This study integrated an in-silico and experimental approach to assess the antihypertensive effects of doxycycline. Bioinformatics analyses were first conducted, including target prediction, gene ontology enrichment, hub-gene identification, PPI network construction, and KEGG pathway analysis, followed by molecular docking and molecular dynamics simulations to predict doxycycline’s interactions with key RAS targets. To validate these computational findings, qRT-PCR was performed to measure the expression of selected genes in kidney tissues from hypertensive rats.

Results: Bioinformatics analysis identified six key target genes, including AGT, AGTR1, AGTR2, REN, ACE, and ACE2. Molecular docking showed that doxycycline exhibited stronger binding affinity to AGTR1 (-8.346 kcal/mol) than its native ligand. Molecular dynamics confirmed the stability of the doxycycline–AGTR1 complex at 20 ns. Gene expression analysis of kidney tissues from hypertensive rats revealed a significant reduction in AGTR1 expression in the group treated with doxycycline 15 mg/kg (p<0.05), while no significant change was observed at 30 mg/kg.

Conclusion: Low-dose doxycycline may modulate the renin–angiotensin pathway through AGTR1 inhibition, indicating its potential as a candidate for further antihypertensive research and warranting more comprehensive in vivo evaluation.

Keywords: Hypertension, doxycycline, molecular docking, gene expression, Renin-Angiotensin System

Full Text:

PDF

References

Jiang Z, Zhai C, Tang G. Novel antihypertensive medications to target the renin-angiotensin system: mechanisms and research. Rev Cardiovasc Med. 2025; 26(4): 27963, CrossRef.

Ramadhanti R, Helda H. Association of hypertension and chronic kidney disease in population aged ≥18 years old. Mol Cell Biomed Sci. 2021; 5(3): 137-44, CrossRef.

Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, et al. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev. 2018; 98(3): 1627-738, CrossRef.

Alam R, Ahsan H, Khan S. The role of malondialdehyde (MDA) and ferric reducing antioxidant power (FRAP) in patients with hypertension. Mol Cell Biomed Sci. 2023; 7(2): 58-64, CrossRef.

Martyniak A, Drożdż D, Tomasik PJ. Classical and alternative pathways of the renin-angiotensin-aldosterone system in regulating blood pressure in hypertension and obese adolescents. Biomedicines. 2024; 12(3): 620-30, CrossRef.

Bader M, Steckelings UM, Alenina N, Santos RAS, Ferrario CM. Alternative renin-angiotensin system. Hypertension. 2024; 81(5): 964-76, CrossRef.

Garcia B, Zarbock A, Bellomo R, Legrand M. The alternative renin-angiotensin system in critically ill patients: pathophysiology and therapeutic implications. Crit Care. 2023; 27(1): 453, CrossRef.

Safitri PGA, Da'i M, Wulandari F. 1'-Acetoxychavicol acetate suppresses osteosarcoma cell proliferation through the PI3K pathway: a molecular docking and cytotoxicity study. Mol Cell Biomed Sci. 2025; 9(2): 105-14, CrossRef.

Taherkhani S, Sheibani M, Mohammadkhanizadeh A, Virag JAI, de Castro Braz L, Azizi Y. Metalloproteinases (MMPs) in hypertensive disorders: role, function, pharmacology, and potential strategies to mitigate pathophysiological changes. Front Pharmacol. 2025; 16: 1559288, CrossRef.

de Oliveira NVG, Blascke MMM, Rodrigues D, Pernomian L, de Oliveira IS, Parente JM, et al. Type I collagen proteolysis by matrix metalloproteinase-2 contributes to focal adhesion kinase activation and vascular smooth muscle cell proliferation in the aorta in early hypertension. Vascul Pharmacol. 2023; 152: 107211, CrossRef.

Blascke de Mello MM, Neves VG O, Parente JM, Pernomian L, de Oliveira IS, Pedersoli CA, et al. Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension. Eur J Pharmacol. 2024; 983: 176981, CrossRef.

Robles-Vera I, de la Visitación N, Toral M, Sánchez M, Romero M, Gómez-Guzmán M, et al. Changes in gut microbiota induced by doxycycline influence in vascular function and development of hypertension in DOCA-salt rats. Nutrients. 2021; 13(9): 2971, CrossRef.

Monayo ER, Arozal W, Noviana D, Barinda AJ, Widyantoro B. Sprague-dawley rats induced by uninephrectomy, DOCA injection, and sodium chloride: a suitable model for chronic hypertension with cardiac hypertrophy. Int J Vet Sci. 2024; 13(5): 623-31, article.

Davis AP, Wiegers TC, Johnson RJ, Sciaky D, Wiegers J, Mattingly CJ. Comparative Toxicogenomics Database (CTD): update 2023. Nucleic Acids Res. 2023; 51(D1): D1257-62, CrossRef.

Berthier CC, Bethunaickan R, Gonzalez-Rivera T, Nair V, Ramanujam M, Zhang W, et al. Cross-Species Transcriptional Network Analysis Defines Shared Inflammatory Responses in Murine and Human Lupus Nephritis. J. Immunol. 2012; 189(2): 988-1001, CrossRef.

Guo F, Zhang W, Su J, Xu H, Yang H. Prediction of drug positioning for quan-du-zhong capsules against hypertensive nephropathy based on the robustness of disease network. Front Pharmacol. 2019; 10: 49, CrossRef.

Chen Z, Wu H, Wang G, Feng Y. Identification of potential candidate genes for hypertensive nephropathy based on gene expression profile. BMC Nephrol. 2016; 17(1): 1-8, CrossRef.

Bioinformatics & Evolutionary Genomics [Internet]. Calculate and draw custom Venn diagrams [updated 2025 January 12 cited by 2025 August 30]. Available from: https://bioinformatics.psb.ugent.be/.

Szklarczyk D, Nastou K, Koutrouli M, Kirsch R, Mehryary F, Hachilif R, et al. The STRING database in 2025: protein networks with directionality of regulation. Nucleic Acids Res. 2025; 53(D1): D730-7, CrossRef.

Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape stringapp: network analysis and visualization of proteomics data. J Proteome Res. 2019; 18(2): 623-32, CrossRef.

Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014; 8(Suppl 4): S11, CrossRef.

Evangelista JE, Xie Z, Marino GB, Nguyen N, Clarke DJB, Ma'Ayan A. Enrichr-KG: bridging enrichment analysis across multiple libraries. Nucleic Acids Res. 2023; 51(1W): W168-79, CrossRef.

Xie Z, Bailey A, Kuleshov M V., Clarke DJB, Evangelista JE, Jenkins SL, et al. Gene set knowledge discovery with enrichr. Curr Protoc. 2021; 1(3): e90, CrossRef.

Xijin Ge S, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020; 36(8): 2628-9, CrossRef.

Burley SK, Berman HM, Bhikadiya C, Bi C, Chen L, Costanzo L Di, et al. Protein data bank: the single global archive for 3d macromolecular structure data. Nucleic Acids Res. 2019; 47(D1): D520-8, article.

National Center for Biotechnology Information [Internet]. PubChem compound summary for CID 54671203, Doxycycline [cited 2025 January 12]. Available from: https://pubchem.ncbi.nlm.nih.gov/.

Sharma J, Kumar BV, Singh R, Rajendran V, Purohit R, Kumar S. An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non-structural protein-15 of SARS-CoV-2. Food Chem. 2021; 346: 128933, CrossRef.

Wagner EM. Monitoring gene expression: Quantitative real-time RT-PCR. Methods Mol Bio. 2013; 1027: 19-45, CrossRef.

Jozefczuk J, Adjaye J. Quantitative real-time PCR-based analysis of gene expression. In: Methods Enzymol. 2011; 500: 99-109, CrossRef.

Zeng X, Yang Y. Molecular mechanisms underlying vascular remodeling in hypertension. Rev Cardiovasc Med. 2024; 25(2): 72. doi: 10.31083/j.rcm2502072, CrossRef.

Chen S, Li B, Chen L, Jiang H. Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation. J Transl Med. 2023; 21(1): 380, CrossRef.

Subramanian I, Verma S, Kumar S, Jere A, Anamika K. Multi-omics data integration, interpretation, and its application. Bioinform Biol Insights. 2020; 14: 1177932219899051. doi: 10.1177/1177932219899051, CrossRef.

Sayed Murad HA., M Rafeeq M, Alqahtani SM, S Rajab B, Alghamdi S, J Almehmadi S, et al. Molecular docking analysis of AGTR1 antagonists. Bioinformation. 2023; 19(3): 284-9, CrossRef.

Zeng Y, Jiang Y, Huang Z, Li K, Zhou Y. Association between AGTR1 (c.1166 A>C) polymorphisms and kidney injury in Hypertension. Front Biosci. 2023 ;28(7): 146. doi: 10.31083/j.fbl2807146, CrossRef.

Guimaraes DA, Rizzi E, Ceron CS, Oliveira AM, Oliveira DM, Castro MM, et al. Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension. Basic Clin Pharmacol Toxicol. 2011; 108(5): 318-25, CrossRef.